Staley Capital Advisers Inc Becton Dickinson & CO Transaction History

Staley Capital Advisers Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$232.09 - $256.88 $4.47 Million - $4.95 Million	-19,255 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$221.92 - $245.94 $88,768 - $98,376	-400 Reduced 2.04%	19,255 $4.82 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $1.04 Million - $1.34 Million	4,834 Added 32.62%	19,655 $4.57 Million
Q2 2020 Aug 07, 2020	BUY	$219.9 - $263.41 $1.69 Million - $2.02 Million	7,685 Added 107.69%	14,821 $3.55 Million
Q1 2020 May 08, 2020	SELL	$195.69 - $279.01 $1.58 Million - $2.25 Million	-8,049 Reduced 53.01%	7,136 $1.64 Million
Q2 2019 Aug 09, 2019	BUY	$217.4 - $246.08 $483,715 - $547,528	2,225 Added 17.17%	15,185 $3.83 Million
Q1 2019 May 10, 2019	BUY	$206.05 - $248.17 $460,521 - $554,659	2,235 Added 20.84%	12,960 $3.24 Million
Q4 2018 Feb 05, 2019	BUY	$204.73 - $257.93 $1.66 Million - $2.09 Million	8,100 Added 308.57%	10,725 $2.42 Million
Q2 2018 Aug 08, 2018	BUY	$208.1 - $233.85 $98,847 - $111,078	475 Added 22.09%	2,625 $629,000
Q1 2018 May 09, 2018	BUY	$205.46 - $240.27 $41,092 - $48,054	200 Added 10.26%	2,150 $466,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,950	1,950 $380,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.6B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Staley Capital Advisers Inc with notifications on news.